Shanghai Invests RMB 120 Million To Boost Biopharma Commercialization
This article was originally published in PharmAsia News
Executive Summary
Shanghai has designated nine key investment areas to boost high-tech industrialization, with the biopharma industry the first to receive funding. The municipal government will allocate a total of RMB 120 million ($17.5 million) to help biopharmaceutical projects and an individual project can receive up to one-tenth of its entire investment. Shanghai Municipality's Science and Technology Commission has published guidelines for fund application. The circular welcomes enterprises in the city that are developing biopharmaceutical products, pharmaceutical chemicals, modernized TCM, medical devices and veterinary drugs, as well as R&D outsourcing companies to submit their projects. Proposals with the potential of being commercialized are a must for obtaining the fund support. (Click here for more - Chinese Language)